These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 19549427

  • 1. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
    Prenner B, Anolik R, Danzig M, Yao R.
    Allergy Asthma Proc; 2009; 30(3):263-9. PubMed ID: 19549427
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [Abstract] [Full Text] [Related]

  • 3. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH, Howland WC, Arastu R, Philpot EE, Klein KC, Baidoo CA, Faris MA, Rickard KA.
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [Abstract] [Full Text] [Related]

  • 4. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.
    Wilson AM, Orr LC, Coutie WJ, Sims EJ, Lipworth BJ.
    Clin Exp Allergy; 2002 Jan; 32(1):126-32. PubMed ID: 12002729
    [Abstract] [Full Text] [Related]

  • 5. Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitis.
    Prenner BM, Lu S, Danzig MR.
    Allergy Asthma Proc; 2010 Jan; 31(6):493-8. PubMed ID: 21708061
    [Abstract] [Full Text] [Related]

  • 6. Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit.
    Day JH, Briscoe MP, Ratz JD, Ellis AK, Yao R, Danzig M.
    Allergy Asthma Proc; 2009 Jan; 30(3):270-6. PubMed ID: 19549428
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS, Philip G, Lu S, Malice MP, Reiss TF, Montelukast Fall Rhinitis Investigator Group.
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [Abstract] [Full Text] [Related]

  • 8. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis.
    Yamamoto H, Yamada T, Sakashita M, Kubo S, Susuki D, Tokunaga T, Ogi K, Terasawa Y, Yamashita S, Kayano Y, Masada M, Kimura Y, Fujieda S.
    Allergy Asthma Proc; 2012 May; 33(2):e17-22. PubMed ID: 22525385
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis.
    Grubbe RE, Lumry WR, Anolik R.
    J Investig Allergol Clin Immunol; 2009 May; 19(2):117-24. PubMed ID: 19476015
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis.
    Pinar E, Eryigit O, Oncel S, Calli C, Yilmaz O, Yuksel H.
    Auris Nasus Larynx; 2008 Mar; 35(1):61-6. PubMed ID: 17826020
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit.
    Day JH, Briscoe MP, Ratz JD, Danzig M, Yao R.
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):328-38. PubMed ID: 19441605
    [Abstract] [Full Text] [Related]

  • 13. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
    Lu S, Malice MP, Dass SB, Reiss TF.
    J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
    [Abstract] [Full Text] [Related]

  • 14. [Effect of nasal glucocorticoid combined with loratadine or montelukast on allergic rhinitis].
    Jia MH, Chen XY, Zhang Y, Liao ZS.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar 05; 31(5):369-373. PubMed ID: 29871264
    [Abstract] [Full Text] [Related]

  • 15. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis.
    Ciebiada M, Gorska-Ciebiada M, Barylski M, Kmiecik T, Gorski P.
    Am J Rhinol Allergy; 2011 Mar 05; 25(1):e1-6. PubMed ID: 21711959
    [Abstract] [Full Text] [Related]

  • 16. Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.
    Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA, Faris MA, Philpot EE.
    Ann Allergy Asthma Immunol; 2006 Jun 05; 96(6):851-7. PubMed ID: 16802774
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W, Grubbe R, Weiss S, Lutsky B.
    Ann Allergy Asthma Immunol; 2005 Mar 05; 94(3):348-54. PubMed ID: 15801245
    [Abstract] [Full Text] [Related]

  • 18. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
    van Adelsberg J, Philip G, LaForce CF, Weinstein SF, Menten J, Malice MP, Reiss TF, Montelukast Spring Rhinitis Investigator Group.
    Ann Allergy Asthma Immunol; 2003 Feb 05; 90(2):214-22. PubMed ID: 12602669
    [Abstract] [Full Text] [Related]

  • 19. A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
    Okubo K, Baba K.
    Allergol Int; 2008 Dec 05; 57(4):383-90. PubMed ID: 18946234
    [Abstract] [Full Text] [Related]

  • 20. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
    Mucha SM, deTineo M, Naclerio RM, Baroody FM.
    Arch Otolaryngol Head Neck Surg; 2006 Feb 05; 132(2):164-72. PubMed ID: 16490874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.